R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.
Richard Mark Kirkner
Advertisement
Richard Mark Kirkner is an independent healthcare journalist in the Greater Philadelphia area.
Articles by Richard Mark Kirkner
Advertisement
Latest Updated Articles
- The market side of biosimilars
Published: August 10th 2015 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
How Community Pharmacists Are Proactively Managing Patients’ Migraines | NCPA 2025
3
The Variety of Migraine Treatment Options Opens the Door for Pharmacy Services | NCPA 2025
4
Pharmacists Help Patients Stay Adherent to COPD Therapy, Improving Overall Quality of Life
5
